James D. Watson

Managing Director

Mr. Watson has broad therapeutic and drug discovery experience in strategy and partnership formation. Prior to joining Burrill & Company, he was a Senior VP with Incyte Genomics heading the Business Development and Marketing organizations. Before Incyte, he was General Manager and previously VP Business Development for Chemdex, a pioneering marketplace for research scientists with over 100 employees. Prior to Chemdex, Mr. Watson was Head of the San Francisco office of The Wilkerson Group where he built the office from 4 to over 30 consultants. Earlier, he gained operational experience with Lilly in Indianapolis and the UK in a variety of new product development and commercially focused roles. Mr. Watson received a Fulbright Scholarship and MBA from Indiana University and lectured in Economics at Portsmouth University, England.